Who's in and who's out of Goldman Sachs' '10 products that will change the industry'?
This article was originally published in Scrip
Executive Summary
Goldman Sachs has updated its annual list of the ten products that it believes can transform the industry, dropping six products from its 2014 list, but keeping the faith in immune-oncology as the largest opportunity for pharma.